Last reviewed · How we verify

Reinforced preventive ARV therapy

ANRS, Emerging Infectious Diseases · FDA-approved active Small molecule Quality 3/100

At a glance

Generic nameReinforced preventive ARV therapy
Also known asEarly diagnosis in children exposed to HIV
SponsorANRS, Emerging Infectious Diseases
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results